Middle-East and Africa Lung Cancer Therapeutics Market by Treatment Type (Chemotherapy (Cisplatin, Taxol, Navelbine, Camptosar and Alimta), Radiotherapy (External Beam, Internal Beam and Systemic) and Other Drugs (Abraxane, Avastin, Crizotinib, Docetaxel and Gefitinib)) and by Region - Industry Analysis, Size, Share, Growth, Trends, and Forecasts (2016–2021)

Middle-East and Africa Lung Cancer Therapeutics Market by Treatment Type (Chemotherapy (Cisplatin, Taxol, Navelbine, Camptosar and Alimta), Radiotherapy (External Beam, Internal Beam and Systemic) and Other Drugs (Abraxane, Avastin, Crizotinib, Docetaxel and Gefitinib)) and by Region - Industry Analysis, Size, Share, Growth, Trends, and Forecasts (2016–2021)

ID: 898 | Pages: 135 | May 2017 | Region: Middle East and Africa


The Middle-East and Africa Lung Cancer Therapeutics Market was worth $0.62 billion in 2016 and estimated to be growing at a CAGR of 6.59%, to reach $0.86 billion by 2021.

Medical improvements have presented effective methods for treatment of lung cancer. Presently, surgery, chemotherapy and radiation therapy are foremost treatment possibilities implemented. Lung cancer is treated majorly with chemotherapy and radiation therapy. The primary lung carcinomas originate from epithelial cells.

The Middle-East and Africa lung cancer therapeutics market would be driven by growing acceptance of modified treatments. Though new drugs have restored the lung cancer therapeutics market, patent expiry of existing drugs has postured a major risk to original drug manufacturers. Still, this has also shaped new chances for generic drug manufacturers to promote low cost generic drugs.

The Middle-East and Africa Lung Cancer Therapeutics Market is segmented on the basis of treatment type nto Chemotherapy, Radiotherapy and Other Drugs. Based on drug type, Lung Cancer Chemotherapy market is segmented into cisplatin, taxol, navelbine, camptosar and Alimta. Based on type, Lung Cancer Radiotherapy market is segregated into external beam, internal beam and systemic. On the basis of drug type, Other Lung Cancer Therapeutic Drugs market is segmented into abraxane, avastin, crizotinib, docetaxel and Gefitinib. The top global brands that are commercially accessible in the market are Avastin, Alimta and taxol. Radiotherapy accounts for the largest segment in the lung cancer therapeutics market.

Based on geography the market is analysed under various regions namely, Middle-East and Africa. Middle-East is anticipated to witness high growth in the forecast period and Africa is expected to dominate the Middle-East and Africa region lung cancer therapeutics market.

Companies are implementing various strategies to increase their product portfolio and rise its geographical presence. New product expansion, contracts and associations and procurements are some of the significant approaches adopted by the manufacturers in the lung cancer therapeutics market. The prominent players of this market include BoehringerIngelheim GmbH, Hoffman-La Roche, Pfizer Inc., GlaxoSmitKline, Eli Lilly and Company, Agennix AG, AstrazenecaPlc, and Sanofi-Aventis.

1. Introduction                                                 

                1.1 Market Definition                                    

                1.2 Study Deliverables                                  

                1.3 Base Currency, Base Year and Forecast Periods                                           

                1.4 General Study Assumptions                                

2. Research Methodology                                                           

                2.1 Introduction                                              

                2.2 Research Phases                                      

                                2.2.1 Secondary Research                            

                                2.2.2 Primary Research                 

                                2.2.3 Econometric Modelling                     

                                2.2.4 Expert Validation                  

                2.3 Analysis Design                                         

                2.4 Study Timeline                                          

3. Overview                                                      

                3.1 Executive Summary                                

                3.2 Key Inferences                                         

                3.3 New Developments                                

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                                                      

                4.1 Market Drivers                                          

                4.2 Market Restraints                                    

                4.3 Key Challenges                                         

                4.4 Current Opportunities in the Market                               

5. Market Segmentation                                                              

                5.1 By Treatment Type                                 

                                5.1.1 Chemotherapy                     

                                                5.1.1.1 Cisplatin

                                                5.1.1.2 Taxol      

                                                5.1.1.3 Navelbine            

                                                5.1.1.4 Camptosar          

                                                5.1.1.5 Alimta   

                                5.1.2 Radiotherapy                         

                                                5.1.2.1 External Beam   

                                                5.1.2.2 Internal Beam    

                                                5.1.2.3 Systemic              

                                5.1.3 Other Drugs                            

                                                5.1.3.1 Abraxane             

                                                5.1.3.2 Avastin 

                                                5.1.3.3 Crizotinib             

                                                5.1.3.4 Docetaxel            

                                                5.1.3.5 Gefitinib               

6. Geographical Analysis                                                              

                6.1 Introduction                                              

                6.2 Brazil                                             

                6.3 Mexico                                         

                6.4 Argentina                                    

                6.5 Rest of Latin America                                             

7. Pipeline Product Analysis                                                       

                7.1 Overview                                                    

                7.2 Pipeline Development Landscape                                                    

                7.3 Molecular Targets in the Pipeline                                                     

                7.4 Clinical Trials                                             

                                7.4.1 Failure Rate by Stage of Development, Indication, Molecule Type and Molecular Target                       

                                7.4.2 Clinical Trial Duration by Stage of Development, Indication, Molecule Type and Molecular Target                                  

                                7.4.3 Clinical Trial Size by Stage of Development, Indication, Molecule Type and Molecular Target.                               

8. Strategic Analysis                                                       

                8.1 PESTLE analysis                                         

                                8.1.1 Political                     

                                8.1.2 Economic                 

                                8.1.3 Social                         

                                8.1.4 Technological                         

                                8.1.5 Legal                          

                                8.1.6 Environmental                      

                8.2 Porter’s Five analysis                                              

                                8.2.1 Bargaining Power of Suppliers                        

                                8.2.2 Bargaining Power of Consumers                    

                                8.2.3 Threat of New Entrants                     

                                8.2.4 Threat of Substitute Products and Services               

                                8.2.5 Competitive Rivalry within the Industry                      

9. Market Leaders' Analysis                                                        

                9.1 BoehringerIngelheim GmbH                               

                                9.1.1 Overview                

                                9.1.2 Product Analysis                   

                                9.1.3 Strategic Evaluation and Operations                            

                                9.1.4 Financial analysis                  

                                9.1.5 Legal issues                            

                                9.1.6 Recent Developments                       

                                9.1.7 SWOT analysis                       

                                9.1.8 Analyst View                          

                9.2 Hoffman-La Roche                                  

                9.3 Pfizer Inc.                                    

                9.4 GlaxoSmitKline                                         

                9.5 Eli Lilly and Company                                             

                9.6 AstrazenecaPlc                                         

                9.7 Sanofi-Aventis                                          

                9.8 Agennix AG                                

10. Competitive Landscape                                                         

                10.1 Market share analysis                                          

                10.2 Merger and Acquisition Analysis                                     

                10.3 Agreements, collaborations and Joint Ventures                                       

                10.4 New Product Launches                                       

11. Expert Opinions                                                        

                11.1 Market Outlook                                     

                11.2 Investment Opportunities                                 

Appendix                                                           

                a) List of Tables                                

                b) List of Figures                                              

  • Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms of technology, component, and type along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
TitlePriceAdd To Cart
  1. Middle East & Africa Lung Cancer Therapeutics Market By Region, From 2016-2021 (USD Billion)
  2. Middle East & Africa Lung Cancer Therapeutics Market By Treatment Type, From 2016-2021 (USD Billion)
  3. Middle East & Africa Chemotherapy Market By Region, From 2016-2021 (USD Billion)
  4. Middle East & Africa Radiotherapy Market By Region, From 2016-2021 (USD Billion)
  5. Middle East & Africa Other Lung Cancer Therapeutic Drugs Market By Region, From 2016-2021 (USD Billion)
  6. Middle East Lung Cancer Therapeutics Market By Treatment Type, From 2016-2021 (USD Billion)
  7. Africa Lung Cancer Therapeutics Market By Treatment Type, From 2016-2021 (USD Billion)
  8. Middle East & Africa Lung Cancer Chemotherapy Market By Drug Type, From 2016-2021 (USD Billion)
  9. Middle East & Africa Cisplatin Market By Region, From 2016-2021 (USD Billion)
  10. Middle East & Africa Taxol Market By Region, From 2016-2021 (USD Billion)
  11. Middle East & Africa Navelbine Market By Region, From 2016-2021 (USD Billion)
  12. Middle East & Africa Camptosar Market By Region, From 2016-2021 (USD Billion)
  13. Middle East & Africa Alimta Market By Region, From 2016-2021 (USD Billion)
  14. Middle East Lung Cancer Chemotherapy Market By Drug Type, From 2016-2021 (USD Billion)
  15. Africa Lung Cancer Chemotherapy Market By Drug Type, From 2016-2021 (USD Billion)
  16. Middle East & Africa Lung Cancer Radiotherapy Market By Type, From 2016-2021 (USD Billion)
  17. Middle East & Africa External Beam Market By Region, From 2016-2021 (USD Billion)
  18. Middle East & Africa Internal Beam Market By Region, From 2016-2021 (USD Billion)
  19. Middle East & Africa Systemic Market By Region, From 2016-2021 (USD Billion)
  20. Middle East Lung Cancer Radiotherapy Market By Type, From 2016-2021 (USD Billion)
  21. Africa Lung Cancer Radiotherapy Market By Type, From 2016-2021 (USD Billion)
  22. Middle East & Africa Other Lung Cancer Therapeutic Drugs Market By Drug Type, From 2016-2021 (USD Billion)
  23. Middle East & Africa Abraxane Market By Region, From 2016-2021 (USD Billion)
  24. Middle East & Africa Avastin Market By Region, From 2016-2021 (USD Billion)
  25. Middle East & Africa Crizotinib Market By Region, From 2016-2021 (USD Billion)
  26. Middle East & Africa Docetaxel Market By Region, From 2016-2021 (USD Billion)
  27. Middle East & Africa Gefitinib Market By Region, From 2016-2021 (USD Billion)
  28. Middle East Other Lung Cancer Therapeutic Drugs Market By Drug Type, From 2016-2021 (USD Billion)
  29. Africa Other Lung Cancer Therapeutic Drugs Market By Drug Type, From 2016-2021 (USD Billion)
Middle East And Africa Psychiatry Therapies Market By Type (Social Psychology, Abnormal Psychology, Biological Psychology And Other Types), By Type Of Medication (Antidepressants, Antipsychotics, Depressants, Anxiol...
Latin America Psychiatry Therapies Market By Type (Social Psychology, Abnormal Psychology, Biological Psychology And Other Types), By Type Of Medication (Antidepressants, Antipsychotics, Depressants, Anxiolytics, Mo...
Asia Pacific Psychiatry Therapies Market By Type (Social Psychology, Abnormal Psychology, Biological Psychology And Other Types), By Type Of Medication (Antidepressants, Antipsychotics, Depressants, Anxiolytics, Moo...
Europe Psychiatry Therapies Market By Type (Social Psychology, Abnormal Psychology, Biological Psychology And Other Types), By Type Of Medication (Antidepressants, Antipsychotics, Depressants, Anxiolytics, Mood Stab...
North America Psychiatry Therapies Market By Type (Social Psychology, Abnormal Psychology, Biological Psychology And Other Types), By Type Of Medication (Antidepressants, Antipsychotics, Depressants, Anxiolytics, Mo...
Psychiatry Therapies Market By Type (Social Psychology, Abnormal Psychology, Biological Psychology And Other Types), By Type Of Medication (Antidepressants, Antipsychotics, Depressants, Anxiolytics, Mood Stabilisers...
Middle East and Africa Home Healthcare Market by Product (Testing, Screening, & Monitoring Products, Therapeutic Products, Mobility Care Products) by Service (Rehabilitation Therapy Services, Infusion Therapy Servic...
Latin America Home Healthcare Market by Product (Testing, Screening, & Monitoring Products, Therapeutic Products, Mobility Care Products) by Service (Rehabilitation Therapy Services, Infusion Therapy Services, Unski...
Asia-Pacific Home Healthcare Market by Product (Testing, Screening, & Monitoring Products, Therapeutic Products, Mobility Care Products) by Service (Rehabilitation Therapy Services, Infusion Therapy Services, Unskil...
Europe Home Healthcare Market by Product (Testing, Screening, & Monitoring Products, Therapeutic Products, Mobility Care Products) by Service (Rehabilitation Therapy Services, Infusion Therapy Services, Unskilled Ca...
North America Home Healthcare Market by Product (Testing, Screening, & Monitoring Products, Therapeutic Products, Mobility Care Products) by Service (Rehabilitation Therapy Services, Infusion Therapy Services, Unski...
Home Healthcare Market by Product (Mobility Care Products ,Screening, & Monitoring Products, Testing, Therapeutic Products) by Service (Infusion Therapy Services, Rehabilitation Therapy Services, Unskilled Care Serv...

"We Think Through Different Layers, We Work Across Different Verticals."

Market Data Forecast, Inc.
2nd Floor, Lakeview Plaza, Kavuri Hills, Hyderabad, Telangana 500033, India.
+1-888-702-9626 (U.S. TOLL FREE)
contact@marketdataforecast.com


Subscribe To Our News Letter

Or follow us on social platform

© 2017 Market Data Forecast
All Rights Reserved.